Abacavir

7 NDCs across 6 manufacturers|7 Generic,0 Brand

Abacavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Abacavir is available as 7 NDCs from 6 manufacturers (7 generic, 0 brand), with NADAC prices from $0.54 to $0.54 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

7G / 0B

Manufacturers

competing in market

Price Spread

$0.54 – $0.54

per EA

7d Activity

7↓0 flat

avg -3.4% WoW · of 7 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

6 manufacturers producing ABACAVIR

Major Pharmaceuticals

2 NDCs

$0.5380

avg/unit

Camber Pharmaceuticals Inc.

Aurobindo Pharma Limited

1 NDC

$0.5380

avg/unit

American Health Packaging

Drug Portfolio

7 NDCs total, 7 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
ABACAVIR 300 MG TABLET	00904687404	Major Pharmaceuticals	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ABACAVIR 300 MG TABLET	00904687406	Major Pharmaceuticals	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ABACAVIR 300 MG TABLET	31722055760	Camber Pharmaceuticals Inc.	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ABACAVIR 300 MG TABLET	50268004912	AvPAK	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ABACAVIR 300 MG TABLET	65862007360	Aurobindo Pharma Limited	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ABACAVIR 300 MG TABLET	68084002121	American Health Packaging	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ABACAVIR 300 MG TABLET	69097051403	Cipla USA Inc.	$0.5380 per EA	—	Generic	-3.37%	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Frequently Asked Questions

What is Abacavir used to treat?

Abacavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

How many Abacavir products are on the market?

The Abacavir drug market contains 7 NDCs from 6 manufacturers — 7 generic and 0 brand products.

What is the price range for Abacavir?

NADAC reference prices for Abacavir range from $0.5380 to $0.5380 per EA.

Which manufacturers make Abacavir?

6 manufacturers list Abacavir in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (2), Camber Pharmaceuticals Inc. (1), AvPAK (1), Aurobindo Pharma Limited (1), American Health Packaging (1).

How has the price of Abacavir changed recently?

Over the past 7 days, 0 Abacavir NDCs rose and 7 fell, with a market-wide average change of -3.4%.